Eugenics and the Human/Animal Divide in Guardians of the Galaxy Vol. 3
By Leigha McReynolds,
Tor
| 09. 19. 2023
The 2011 X-Men franchise prequel, X-Men: First Class, briefly featured a mutant named Darwin who could adapt to any circumstances. For example, when he stuck his head in a fish tank he grew gills. Now if you’re a history of science nerd like me, you both appreciate the Darwinian reference and wish that the movie had instead named the character Lamarck, who theorized that individual animals could adapt to environments and experience physical changes during their lives—but that doesn’t have quite the same ring to it. Darwin, on the other hand, believed that species changed through heredity and over many generations.
While in this case the slippage between evolutionary theorists and their ideas is harmless, there is a long tradition of misusing Darwin’s theory of evolution through natural selection to explain and justify concepts that are not scientific but are actually actively harmful. The creation and deployment of the term “social Darwinism” is one, and the development of the pseudoscience of eugenics in the late nineteenth century is another. Eugenics took concepts rooted in Darwin’s evolutionary theory and used...
Related Articles
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Darren Incorvaia, Fierce Biotech | 03.11.2026
A new method for safely inserting large chunks of DNA into genomes has now measured up in mice, potentially paving the way for the next generation of gene editing medicines.
The approach, which is described in a Nature paper...